Characterization of an expanded set of assays for immunomodulatory proteins using targeted mass spectrometry
Abstract Immunotherapies are revolutionizing cancer care, but many patients do not achieve durable responses and immune-related adverse events are difficult to predict. Quantifying the hundreds of proteins involved in cancer immunity has the potential to provide biomarkers to monitor and predict tum...
Main Authors: | Jeffrey R. Whiteaker, Lei Zhao, Regine M. Schoenherr, Dongqing Huang, Jacob J. Kennedy, Richard G. Ivey, Chenwei Lin, Travis D. Lorentzen, Simona Colantonio, Tessa W. Caceres, Rhonda R. Roberts, Joseph G. Knotts, Joshua J. Reading, Candice D. Perry, Sandra S. Garcia-Buntley, William Bocik, Stephen M. Hewitt, Amanda G. Paulovich |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-06-01
|
Series: | Scientific Data |
Online Access: | https://doi.org/10.1038/s41597-024-03467-x |
Similar Items
-
A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials
by: Jeffrey R. Whiteaker, et al.
Published: (2023-05-01) -
Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens
by: Jeffrey R. Whiteaker, et al.
Published: (2021-11-01) -
RNA and phosphoprotein profiles of TP53- and PTEN-knockouts in MCF10A at baseline and responding to DNA damage
by: ChenWei Lin, et al.
Published: (2024-01-01) -
The Development and Characterization of Two Monoclonal Antibodies Against the Conjugates and Derivatives of the Immunometabolite Itaconate
by: Lauren Switala, et al.
Published: (2024-12-01) -
Targeted mass-spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP kinase, and AKT signaling
by: Jeffrey R. Whiteaker, et al.
Published: (2021-07-01)